Document is current

Article History

Received: 12 September 2017

Accepted: 18 January 2018

First Online: 5 February 2018

Ethics approval and consent to participate

: The study was approved by the Ethics Committee of the German Psychological Association (reference number NH032107). Ethical approval was received on 25 April 2017. All patients will have to provide signed informed consent before inclusion in the study. There are no plans for protocol modification.

: Not applicable.

: The authors declare that they have competing interests.MS received speakers’ honoraria from Medtronic and Lilly Diabetes Germany.CA has no conflict of interest.DE received speakers’ honoraria from Berlin Chemie AG and Roche Diabetes Care.TH is an advisory board member of Roche Diabetes Care, Sanofi, and Lilly. He received speakers’ honoraria from Berlin Chemie AG, Lilly, and AstraZeneca.BK is an advisory board member of Berlin Chemie AG, Roche Diabetes Care, Novo Nordisk, Medtronic, and Ascensia Diabetes Care. He received speakers’ honoraria from Berlin Chemie AG, Novo Nordisk, Roche Diabetes Care, Abbott, Lilly, and Ascensia Diabetes Care. He has received grants in support of investigator trials from Berlin Chemie AG, Abbott, and Roche Diabetes Care.NH is an advisory board member of Novo Nordisk, Abbott, Lilly, Roche Diabetes Care, and Ypsomed. He received speakers’ honoraria from Novo Nordisk, Abbott, Berlin Chemie AG, Lilly, and Ypsomed. He has received grants in support of investigator trials from Dexcom, Berlin Chemie AG, Ypsomed, Abbott, and Roche Diabetes Care.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.